However, a study by Singer et al. demonstrated that partial reduction of BACE1 through RNA interference improved amyloid pathology and cognitive deficits in APP Tg mice, suggesting that even moderate inhibition of BACE1 could be therapeutically beneficial. Here, BACE1 is linked to amyloidosis.